EXECUTIVE DIRECTOR - ONCOLOGY EARLY DEVELOPMENT LEADER

Site Name.
USA - Pennsylvania - Upper Providence, GSK HQ, Switzerland - Zug, UK - Hertfordshire - Stevenage, USA - Massachusetts - Waltham, Warsaw Rzymowskiego 53 Posted Date.
Dec Are you energized by a scientific leadership opportunity that allows you to develop medicines and shape the scientific program for a growing oncology pipeline?  If so, this Executive Director - Oncology Early Development Leader position could be an ideal opportunity to explore.
The Early Development Leader (EDL) is a critical role within GSK R&D Oncology which reports to the VP EDLs.
The EDL is the single point of accountability to strategically lead the development of a medicine between Candidate Selection (CS) and through Proof of Concept, substantially contributing to defining the early development strategy for an asset.
By working with various stakeholders across R&D, Commercial and Manufacturing, they obtain and manage associated resources, and deliver evidence in line with the strategic vision and organizational strategy to support progression beyond early development for a clearly differentiated medicine.
You’ll play a critical role in the development of GSK’s Oncology pipeline, guiding products through the development process and making a genuine personal impact on the GSK, and wider, oncology therapy area.
Additionally, through the successful deliver of this role you will build a fantastic internal and external network, and a position as an industry leading authority in Oncology R&D.
Key Responsibilities.
Strategic leadership and single point of accountability for the development of an asset or portfolio of assets within R&D, from candidate selection through Proof of Concept.
Contributing to and establishing the development strategy aligned with Medicine Profile (MP) with input and alignment from late stage development, franchise commercial, and medical.
Makes clear evidence-based go / no go / accelerate decisions, based on whether the results fulfil the strategy set out for the medicine, and identify clear inflection points.
Identifies and engages the external community appropriately in robust scientific dialogue that generates insight and advances scientific and medical understanding.
Ensures timely and appropriate interaction and exchange of information between GSK and external communities (e.
., patients, physicians, payers, regulators), in strict adherence with GSK Policies, and GSK Global Scientific Engagement Principles and Standards.
Ensures balanced and robust scientific communications in all formats.
Proactively identifies unique regulatory requirements that are necessary for the development of early stage development e.
.
introduction of first dosing in patient populations, clinical pharmacology and metabolism.
Anticipates the changing healthcare & competitive environment and delivers innovative strategies and plans to generate evidence for relevant pharmacology/efficacy and prescribing/ usage within this environment.
Understands the impact of new data on the value/positioning of products in guidelines/formularies.
When necessary in early stage, partners with Business Development to facilitate diligence reviews, product positioning and/or alternative business strategies (e.
., public private partnerships, co-development) and internal review and decision-making processes in line with GSK governance procedures as well as use of appropriate alliance management mechanisms to ensure successful business transactions and relationships.
Models GSK values and leadership expectations.
Why You? Basic Qualifications.
Experience in oncology clinical development, including early stage oncology and it’s connections with late stage development Has the ability to translate pre-clinical data to develop an oncology clinical development program Has managed and developed individuals and teams in a matrix environment Experience of working across preclinical medicine development, translational medicine, including experimental medicine design and its application End to end clinical development exposure and accountability for all aspects of the strategic planning through to PoC which enables progression beyond PoC.
Preferred Qualifications.
Advanced degree such as MD, PhD, or PharmD, or equivalent is highly preferable Three (3) or more years’ experience leading oncology development programs with experience fulfilling requirements of regulatory filings to initiate clinical testing (e.
.
IND).
Experience leading or participating in Business Development/Due Diligence activities Experience leading or participating in late stage (Phase 3) clinical development program Experience leading or participating in commercial product launch activities.
*LI-GSK Please visit  GSK US Benefits Summary t o learn more about the comprehensive benefits program GSK offers US employees.
Why GSK? Uniting science, technology and talent to get ahead of disease together.
GSK is a global biopharma company with a special purpose – to unite science, technology and talent to get ahead of disease together – so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns – as an organisation where people can thrive.
We prevent and treat disease with vaccines, specialty and general medicines.
We focus on the science of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/ immunology and oncology).
Our success absolutely depends on our people.
While getting ahead of disease together is about our ambition for patients and shareholders, it’s also about making GSK a place where people can thrive.
We want GSK to be a place where people feel inspired, encouraged and challenged to be the best they can be.
A place where they can be themselves – feeling welcome, valued, and included.
Where they can keep growing and look after their wellbeing.
So, if you share our ambition, join us at this exciting moment in our journey to get Ahead Together.
If you require an accommodation or other assistance to apply for a job at GSK, please contact the GSK Service Centre at (US Toll Free) or + (outside US).
GSK is an Equal Opportunity Employer and, in the US, we adhere to Affirmative Action principles.
This ensures that all qualified applicants will receive equal consideration for employment without regard to race, color, national origin, religion, sex, pregnancy, marital status, sexual orientation, gender identity/expression, age, disability, genetic information, military service, covered/protected veteran status or any other federal, state or local protected class.
Important notice to Employment businesses/ Agencies GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site.
All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK.
The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK.
In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK.
GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.
Please note that if you are a US Licensed Healthcare Professional or Healthcare Professional as defined by the laws of the state issuing your license, GSK may be required to capture and report expenses GSK incurs, on your behalf, in the event you are afforded an interview for employment.
This capture of applicable transfers of value is necessary to ensure GSK’s compliance to all federal and state US Transparency requirements.
For more information, please visit GSK’s Transparency Reporting For the Record site.